ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,036.26
0.36%
Dow Jones
38,049.18
0.38%
US Dollar vs MXN
16.92808
-0.09%
Brent Oil
83.605
0.08%
Bitcoin
59,017.14
1.34%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Galectin Therapeutics Inc (GALT)

  7. Galectin Therapeutics Inc (GALT) Noticias

GALT Galectin Therapeutics Inc

3.23
-0.27 (-7.71%)
Última actualización: 11:26:11
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Galectin Therapeutics Inc GALT NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
-0.27 -7.71% 3.23 11:26:11
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
3.51 3.23 3.54 3.50
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
04/3/202411:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/2/202415:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/2/202415:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/2/202415:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/2/202415:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/2/202415:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/2/202415:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/2/202415:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/2/202415:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/2/202415:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/2/202415:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/2/202415:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/1/202410:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/1/202407:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/12/202307:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/12/202315:15EDGAR2Form 8-K - Current report
07/12/202310:42EDGAR2Form 8-K - Current report
01/12/202315:50EDGAR2Form 5 - Annual statement of changes in beneficial ownership..
01/12/202315:38EDGAR2Form SC 13D/A - General statement of acquisition of..
01/12/202307:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/11/202316:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202308:21EDGAR2Form 8-K/A - Current report: [Amend]
13/11/202307:45GLOBEUPDATE – Galectin Therapeutics Reports Financial Results for..
13/11/202307:00GLOBEGalectin Therapeutics Reports Financial Results for the..
13/11/202306:55EDGAR2Form 8-K - Current report
13/11/202306:50EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/11/202307:00GLOBEGalectin Therapeutics to Share Five Scientific Presentations..
31/10/202315:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/10/202307:00GLOBEGalectin Therapeutics to Participate in the H.C. Wainwright..
16/10/202307:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/10/202307:00GLOBEGalectin Therapeutics Announces Nomination of Dr. Benjamin..
06/10/202307:05EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
06/10/202307:03EDGAR2Form DEF 14A - Other definitive proxy statements
03/10/202307:00GLOBEGalectin Therapeutics Reports the Positive Outcome of the..
02/10/202306:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/9/202313:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/9/202307:00GLOBEGalectin Therapeutics to Present Update on its Belapectin..
18/9/202308:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/9/202315:38EDGAR2Form 144 - Report of proposed sale of securities
11/9/202307:00GLOBEGalectin Therapeutics to Participate in the H.C. Wainwright..
07/9/202311:00GLOBEGalectin Therapeutics to Present Data on Liver Cirrhosis at..
01/9/202306:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/8/202315:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/8/202307:00GLOBEGalectin Therapeutics Reports Financial Results for the..
14/8/202306:55EDGAR2Form 8-K - Current report
14/8/202306:51EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
31/7/202315:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/7/202306:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/7/202307:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/7/202306:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Su Consulta Reciente

NASDAQ
GALT
Galectin Therapeutics
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados